Alcon AG (ALC)vsDaxor Corporation (DXR)
ALC
Alcon AG
$75.26
+1.37%
HEALTHCARE · Cap: $37.11B
DXR
Daxor Corporation
$10.23
-2.66%
HEALTHCARE · Cap: $63.75M
Smart Verdict
WallStSmart Research — data-driven comparison
Alcon AG generates 38969552% more annual revenue ($10.40B vs $26,690). DXR leads profitability with a 343.6% profit margin vs 9.4%. DXR trades at a lower P/E of 6.7x. ALC earns a higher WallStSmart Score of 49/100 (D+).
ALC
Hold49
out of 100
Grade: D+
DXR
Hold45
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-489.8%
Fair Value
$13.46
Current Price
$75.26
$61.80 premium
Margin of Safety
+83.6%
Fair Value
$76.75
Current Price
$10.23
$66.52 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Keeps 344 of every $100 in revenue as profit
Every $100 of equity generates 23 in profit
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
ROE of 4.5% — below average capital efficiency
Earnings declined 22.2%
3.3% earnings growth
Smaller company, higher risk/reward
Revenue declined 82.6%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : ALC
The strongest argument for ALC centers on Debt/Equity, Price/Book.
Bull Case : DXR
The strongest argument for DXR centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 343.6% and operating margin at -96.6%.
Bear Case : ALC
The primary concerns for ALC are PEG Ratio, P/E Ratio, Return on Equity.
Bear Case : DXR
The primary concerns for DXR are EPS Growth, Market Cap, Revenue Growth.
Key Dynamics to Monitor
ALC profiles as a value stock while DXR is a declining play — different risk/reward profiles.
ALC carries more volatility with a beta of 0.70 — expect wider price swings.
ALC is growing revenue faster at 8.6% — sustainability is the question.
ALC generates stronger free cash flow (489M), providing more financial flexibility.
Bottom Line
ALC scores higher overall (49/100 vs 45/100). DXR offers better value entry with a 83.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Alcon AG
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Visit Website →Daxor Corporation
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?